Determinant [ftcn]    
HEPATOCELLULAR CARCINOMA [neop]    
Cirrhotic [qlco]    
Patients [podg]    
Treated [ftcn]    
Ide [fish]    
Analogue [chvs]    
Hepatitis B, Chronic [dsyn]    
Determinant [ftcn]    
HEPATOCELLULAR CARCINOMA [neop]    
Cirrhotic [qlco]    
Patients [podg]    
RECEIVED [qlco]    
Ide [fish]    
Analogue [chvs]    
Hepatitis B, Chronic [dsyn]    
Retrospective Study [resa]    
prospective [resa]    
screen [hlca]    
Patients [podg]    
RECEIVED [qlco]    
Antiviral Therapy [topp]    
Hepatitis B, Chronic [dsyn]    
September [tmco]    
March [qlco]    
DA [geoa]    
Consecutive [qlco]    
Cirrhotic [qlco]    
Patients [podg]    
Pretreatment [sbst]    
DNA, Viral [nnon]    
2000s [tmco]    
IU/mL [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
3 Months [tmco]    
treatment [ftcn]    
Excluded [idcn]    
participants [popg]    
Observed [ftcn]    
occurrence [ftcn]    
HEPATOCELLULAR CARCINOMA [neop]    
DEATH [orgf]    
January [qlco]    
Determinant [ftcn]    
HEPATOCELLULAR CARCINOMA [neop]    
Estimated [qnco]    
risk analysis [qlco]    
Adjusted [ftcn]    
Mortality [qnco]    
Thirty [qnco]    
Five [qnco]    
Patients [podg]    
HEPATOCELLULAR CARCINOMA [neop]    
Median [spco]    
Cumulative [qlco]    
CI [geoa]    
YEARS [tmco]    
Multivariate Analyses [qnco]    
Adjusted [ftcn]    
Identified [qlco]    
YEARS [tmco]    
Adjusted [ftcn]    
Hazard Ratio [qnco]    
2-19 [gngm]    
CI [geoa]    
Male Gender [orga]    
Adjusted [ftcn]    
Hazard Ratio [qnco]    
CI [geoa]    
1 - 9% [fndg]    
Model for End-Stage Liver Disease [clas]    
MELD score [clna]    
POINT [qnco]    
Adjusted [ftcn]    
Hazard Ratio [qnco]    
CI [geoa]    
1-10 [fndg]    
DIABETES MELLITUS [dsyn]    
DM [dsyn]    
Adjusted [ftcn]    
Hazard Ratio [qnco]    
CI [geoa]    
1-7 [gngm]    
Independent [idcn]    
Risk Factors [qnco]    
MULTIPLE [qnco]    
Including [ftcn]    
Medication [phsu]    
scoring [qnco]    
Formula [inpr]    
INFORMATION [idcn]    
Gender [orga]    
MELD score [clna]    
DM [dsyn]    
Regimen [topp]    
Discriminate [qlco]    
Patients [podg]    
Low Risk [fndg]    
HEPATOCELLULAR CARCINOMA [neop]    
SENSITIVITY AND SPECIFICITY [qnco]    
Gender [orga]    
Hepatic dysfunction [patf]    
DM [dsyn]    
Medication [phsu]    
DM [dsyn]    
baseline [bodm]    
HEPATOCELLULAR CARCINOMA [neop]    
Cirrhotic [qlco]    
Patients [podg]    
Receive [qlco]    
Ide [fish]    
Analogue [chvs]    
Hepatitis B, Chronic [dsyn]    
